Erythromycin topical Pregnancy and Breastfeeding Warnings

Erythromycin topical is also known as: A/T/S, Akne-Mycin, E-Solve 2, Emcin Clear, Emgel, Ery Pads, Ery-Sol, Erycette, Eryderm, Erygel, Erymax, Erythra-Derm, Romycin, Staticin, T-Stat, Theramycin, Theramycin Z

Erythromycin topical Pregnancy Warnings

Erythromycin topical gel, 1.5% solution, and swabs (i.e., pledgets, pads) have been assigned to pregnancy category B by the FDA. Erythromycin 2% topical solution has been assigned to pregnancy category C or B by the FDA; for example, Erythra-Derm(TM) has been assigned to pregnancy category C and Fougera(R) Erythromycin Topical Solution USP 2% has been assigned to pregnancy category B. Erythromycin topical ointment has not been formally assigned to a pregnancy category by the FDA. Animal studies have failed to reveal evidence of teratogenicity. There are no controlled data in human pregnancy, and there have been no reports of adverse fetal effects in humans. Erythromycin topical is only recommended for use during pregnancy when benefit outweighs risk.

Erythromycin topical Breastfeeding Warnings

There are no data on the excretion of erythromycin topical into human milk. Systemically administered erythromycin is excreted into milk in small amounts. Erythromycin is considered compatible with breast-feeding by the American Academy of Pediatrics.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Hide
(web1)